PB2266: TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA (OLYMPIA-5)

• Umberto Vitolo,
• Elizabeth H. Phillips,
• Aránzazu Alonso Alonso,
• Michele Merli,
• Ashish Risal,
• Manjusha Namuduri,
• Biyi Shen,
• Dina Flink,
• Min Zhu,
• Sushmita Mukherjee,
• Jurriaan Brouwer-Visser,
• Aafia Chaudhry,
• Hesham Mohamed,
• Srikanth Ambati,
• Raul Cordoba

Affiliations

Umberto Vitolo

1 Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Turin), Italy

Elizabeth H. Phillips

2 University of Manchester, Manchester, United Kingdom

Aránzazu Alonso Alonso

3 Hospital Universitario Quirónsalud Madrid, Madrid, Spain

Michele Merli

4 Ospedale di Circolo e Fondazione Macchi, Varese, Italy

Ashish Risal

5 Regeneron Pharmaceuticals, Inc.,, Tarrytown, NY, United States

Manjusha Namuduri

5 Regeneron Pharmaceuticals, Inc.,, Tarrytown, NY, United States

Biyi Shen

5 Regeneron Pharmaceuticals, Inc.,, Tarrytown, NY, United States

Dina Flink

5 Regeneron Pharmaceuticals, Inc.,, Tarrytown, NY, United States

Min Zhu

5 Regeneron Pharmaceuticals, Inc.,, Tarrytown, NY, United States

Sushmita Mukherjee

5 Regeneron Pharmaceuticals, Inc.,, Tarrytown, NY, United States

Jurriaan Brouwer-Visser

5 Regeneron Pharmaceuticals, Inc.,, Tarrytown, NY, United States

Aafia Chaudhry

5 Regeneron Pharmaceuticals, Inc.,, Tarrytown, NY, United States

Hesham Mohamed

5 Regeneron Pharmaceuticals, Inc.,, Tarrytown, NY, United States

Srikanth Ambati

5 Regeneron Pharmaceuticals, Inc.,, Tarrytown, NY, United States

Raul Cordoba

6 Fundación Jiménez Díaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain